CAMAISA ALLAN (CEO, President and Chairman) received a stock award from CALIDI BIOTHERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/30/2024ACC: 0001493152-24-038877
DirectorOfficer10% Owner· CEO, President and Chairman
Since Sep 2023
+70.16K
Net shares
Net buyer
$80.7K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
70.16K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+70.16K
Price / share
$1.15
Trade value
$80.68K
% of position
1069.9%
9/26/2024
6.56K→76.71K
Total
Net shares
+70.16K
Net value
$80.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/26/2024 | A · Award | +70.16K | $1.15 | $80.68K | 1069.9% | 6.56K | 76.71K |
| Total | +70.16K | $80.68K | ||||||
Derivative Transactions0
No derivative transactions reported